Canadian Diabetes Association Clinician Scientist Award, 2013-18
2013: Awarded to Dr. JM Gamble to study the comparative safety and effectiveness of the incretin-based therapies.
Adjunct Scientist ICES Central Chronic Disease & Pharmacotherapy Research Program
JM is a Clinical Associate Professor at the University of Waterloo in the School of Pharmacy and holds adjunct appointments with the University of Toronto and McMaster University. He completed his doctoral studies in Public Health Sciences at the University of Alberta and pharmacy training. JM’s research team conducts epidemiologic studies in the space of drug safety and effectiveness primarily through knowledge syntheses and observational drug studies. His other research interests include critical appraisal and communication of drug information, quantitative benefit-risk analysis, and evidence-based monitoring of medications. He has contributed to over 90 peer-reviewed manuscripts and received funding from the Canadian Institutes of Health Research (CIHR), Diabetes Canada, the Heart and Stroke Foundation of Canada, and the Canadian Foundation for Innovation. JM continues to practice as a pharmacist in a family health team-based diabetes clinic.
"*" indicates required fields